Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO · Mar 11, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how soft tissue sarcomas, which are rare types of tumors, affect patients' movement and overall quality of life. The researchers want to explore how robotic rehabilitation techniques can help improve motor skills in patients who have undergone surgery for localized soft tissue sarcoma. They will measure how patients move and how their muscles work using special assessments. Additionally, the trial will look at how nutrition impacts recovery and quality of life, with participants filling out questionnaires at different times during the study.

To be eligible for this trial, participants must be at least 18 years old and have a localized soft tissue sarcoma that can be treated with limb-sparing surgery. Unfortunately, those with recurrent tumors, metastatic disease (cancer that has spread), or who are pregnant or breastfeeding cannot participate. If you join the study, you can expect to undergo evaluations of your movement and receive tailored rehabilitation to help you recover better after surgery. This research aims to provide insights into improving care for patients with soft tissue sarcoma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. patient with primary and localized STS who is a candidate for limb-sparing surgery or retroperitoneal multivisceral resection (including partial or complete resection of the iliopsoas muscle with functional loss and potential femoral nerve involvement) with curative intent;
• • 2. age 18 years or older.
• Exclusion Criteria:
• • 1. recurrent tumors;
• • 2. metastatic disease;
• • 3. candidate for palliative and non-radical surgery;
• • 4. refusal to sign informed consent;
• • 5. Pregnant or breastfeeding women at the time of screening.